Evidence map›Paper›PMID 34719006›Full record

ArticleHuman cell2022

Colorectal cancer promoter methylation alteration affects the expression of glutamate ionotropic receptor AMPA type subunit 4 alternative isoforms potentially relevant in colon tissue.

Ana Florencia Vega-Benedetti, Eleonora Loi, Loredana Moi, Angelo Restivo, Francesco Cabras, Simona Deidda, Andrea Pretta, Pina Ziranu, Sandra Orrù, Mario Scartozzi and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Human cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Association ofInternational journal of molecular sciences · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Frontiers in immunology · 2022
    Article
  12. DNA methylation alterations caused byFrontiers in cellular and infection microbiology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Ana Florencia Vega-Benedetti *Department of Biomedical Sciences, Unit of Biology and Genetics, University of Cagliari, Cittadella Universitaria di Monserrato, Cagliari, Italy.
Eleonora Loi *Department of Biomedical Sciences, Unit of Biology and Genetics, University of Cagliari, Cittadella Universitaria di Monserrato, Cagliari, Italy.
Loredana MoiDepartment of Biomedical Sciences, Unit of Biology and Genetics, University of Cagliari, Cittadella Universitaria di Monserrato, Cagliari, Italy.
Angelo RestivoDepartment of Surgery, Colorectal Surgery Center, University of Cagliari, Cagliari, Italy.
Francesco CabrasDepartment of Surgery, Colorectal Surgery Center, University of Cagliari, Cagliari, Italy.
Simona DeiddaDepartment of Surgery, Colorectal Surgery Center, University of Cagliari, Cagliari, Italy.
Andrea PrettaDepartment of Medical Oncology, University Hospital of Cagliari, Cagliari, Italy.
Pina ZiranuDepartment of Medical Oncology, University Hospital of Cagliari, Cagliari, Italy.
Sandra OrrùDepartment of Pathology, "A. Businco" Oncologic Hospital, ASL Cagliari, Cagliari, Italy.
Mario ScartozziDepartment of Medical Oncology, University Hospital of Cagliari, Cagliari, Italy.
Luigi ZorcoloDepartment of Surgery, Colorectal Surgery Center, University of Cagliari, Cagliari, Italy.
Patrizia ZavattariDepartment of Biomedical Sciences, Unit of Biology and Genetics, University of Cagliari, Cittadella Universitaria di Monserrato, Cagliari, Italy. pzavattari@unica.it.ORCID http://orcid.org/0000-0002-0481-092X
University of Cagliari · IT

Funding

Fondazione Banco di Sardegna 2012Fondazione di Sardegna Prot. U278.2021/AI.259.RPFondo per la Ricerca Locale (ex 60%), Università di Cagliari 2012-2021Italian University Minister PON-AIM F74I18000200001Regione Autonoma della Sardegna 1C-177Regione Autonoma della Sardegna CRP-79303
6 · The paper itself

Abstract

DNA methylation alterations are early events during tumourigenesis, affecting genes involved in the crosstalk between cells and surroundings in colorectal cancer (CRC). Among these genes, GRIA4, Glutamate Ionotropic Receptor AMPA Type Subunit 4, displays hypermethylation in the promoter region, and is an early diagnostic biomarker. It is well known that methylation can also affect alternative transcription. The purpose of this study is to evaluate the expression, at transcript and protein level, of GRIA4 main isoforms (the canonical one and a short variant) in 23 CRC and matched normal samples, of which we previously verified the methylation status. We further predicted miRNA/transcript target interactions as a possible post-transcriptional regulation using bioinformatics tools. As expected, downregulation of both variants has been observed in tumours. Interestingly, in contrast to what observed at transcriptional level, the GluR4 protein short isoform displayed higher expression than the canonical one either in normal or tumoural tissues. This may be explained by miRNA specifically targeting the canonical isoform. Our study is the first one that shows the expression of both isoforms in colon tissues. To note, the evident expression of the short isoform suggests a functional role in intestinal cell biology.

Indexed as

DNA MethylationCarcinogenesisColonColorectal NeoplasmsGene ExpressionGene Expression Regulation, NeoplasticHumansProtein IsoformsReceptors, AMPAglutamate receptor ionotropic, AMPA 4Protein IsoformsReceptors, AMPAColorectal cancer (CRC)DNA methylation alterationsGene expressionGene regulationGRIA4

Identifiers

PMID34719006
PMCPMC8732896
OpenAlexW3208554899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.